A study by Eleftheriou and colleagues indicated that inhibiting BMP9 decreases tumor volume, while increasing vascular branching and metastases (154), suggesting that BMP9 may cause certain cancer cells to proliferate, while also promoting vascular quiescence. The gene discussed is GDF2; the disease is cancer.